HER2 NEGATIVE BREAST CANCER

This adverse event was reported 51 times

These drugs are most commonly taken by patients reporting HER2 NEGATIVE BREAST CANCER:

# Drug Count
0 RIBOCICLIB 21
1 LETROZOLE 10
2 LETROZOLE TABLETS 10
3 FULVESTRANT 8
4 PERTUZUMAB 7
5 TRASTUZUMAB 6
6 ANASTROZOLE 5
7 ANASTROZOLE TABLETS 5
8 PACLITAXEL 5
9 DENOSUMAB 4
See all common drugs associated with HER2 NEGATIVE BREAST CANCER

HER2 NEGATIVE BREAST CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RIBOCICLIB 21 0.0006
1 PAMIDRONATE DISODIUM 1 0.0003
2 PERTUZUMAB 7 0.0003
3 FULVESTRANT 8 0.0002
4 ANASTROZOLE TABLETS 5 0.0002
5 SACITUZUMAB GOVITECAN 1 0.0002
6 LETROZOLE TABLETS 10 0.0002
7 LETROZOLE 10 0.0002
8 ANASTROZOLE 5 0.0001
9 ADO-TRASTUZUMAB EMTANSINE 1 0.0001
See all drugs enriched for association with HER2 NEGATIVE BREAST CANCER